Cannabis-Induced Chronic Psychosis: An Underacknowledged Disorder?

Castle DJ Ames FR. Cannabis and the brain. Australian and New Zealand Journal of Psychiatry 1996; 30:179–183.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.

Glass DS Bowers MB Jr. Chronic psychosis associated with long-term psychotomimetic drug use. Archives of General Psychiatry 1970; 23:997–1003.

Bowers MB Jr. The role of drugs in the production of schizophreniform psychoses and related disorders. In: Lipton MA di Mascio A Killem KF , eds. Psychopharmacology: a generation of progress. New York: Raven, 1978:819–823.

Boutros NN Bowers MB Jr. Chronic substance-induced psychotic disorders: the state of the literature. Journal of Neuropsychiatry and Clinical Neurosciences 1996; 8:262.

Tunving K. Psychiatric effects of cannabis use. Acta Psychiatrica Scandinavica 1985; 72:133–136.

Tennant FS Groesbeck CJ. Psychiatric aspects of hashish. Archives of General Psychiatry 1972; 27:133–136.

Andreasson S Allebeck P Engstrom A Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; II: 1483–1486.

Linszen DH Dingemans PM Lenior ME. Cannabis abuse and the course of recent-onset schizophrenia disorders. Archives of General Psychiatry 1994; 51:273–279.

Allebeck P Adamson C Engstrom A. Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County. Acta Psychiatrica Scandinavica 1993; 88:21–24.

Andreasson S Allebeck P Ryberg U. Schizophrenia in users and non-users of cannabis: a longitudinal study in Stockholm County. Acta Psychiatrica Scandinavica 1989; 79:505–510.

Breakey WR Goodell H Lorenz PC Hallucinogenic drugs as precipitants of schizophrenia. Psychological Medicine 1974; 4:255–261.

Cleghorn JM Kaplan RD Szechman B Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. Journal of Clinical Psychiatry 1991; 52:26–30.

Arndt S Tyrrell G Flaum M Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychological Medicine 1992; 22:379–388.

Bowers MB Jr. Mazure CM. Nelson JC et al. Psychotogenic drug use and neuroleptic response. Schizophrenia Bulletin 1990; 16:81–85.

Castle DJ Ames FR. Cannabis and the brain. Australian and New Zealand Journal of Psychiatry 1996; 30:179–183.

Andreasson S Allebeck P Engstrom A Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; II: 1483–1485.

McGuire PK Jones P Harvey I Williams M McGuffin P Murray RM. Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophrenia Research 1995; 15:277–281.

Patton G. An epidemiological case for separate adolescent psychiatry? Australian and New Zealand Journal of Psychiatry 1996; 5:563–566.

Stein C. Trends in adolescent psychopathology. Canadian Journal of Psychiatry 1982; 27:301–306.

Mayer-Gross Slater Roth Schizophrenia In: Slater Roth , eds. Clinical psychiatry. 3rd ed. Baltimore: Williams and Wilkins, 1969:237–238.

Watkins W. Affective disorders in childhood and adolescence. In: Joyce PR Romans SE Ellis PM Silverstone TS , eds. Affective disorders. New Zealand: University of Otago, 1995:215–239.

Engstrom M. Manic depressive illness in adolescence. Journal of the American Academy of Child and Adolescent Psychiatry 1978; 17:514–525.

Flament M Whitaker A Rapoport J. Obsessive compulsive disorder in adolescence—an epidemiological study. Journal of the American Academy of Child and Adolescent Psychiatry 1988; 27:764–771.

Burke D Fanker S. Fluoxetine and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Australian and New Zealand Journal of Psychiatry 1996; 30:295–298.

Moses AM Streeten DHP. Disorders of the neurohypophysis. In: Isselbacher KJ Braunwald E Wilson JD Martin JB Fauci AS Kasper DL , eds. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994:1928–1930.

Abbott R. Hyponatraemia due to antidepressant medications. Annals of Emergency Medicine 1983; 12:708–710.

Ayonrinde OT Reutens SG Sanfilippo FM. Paroxetine-induced SIADH [letter]. Medical Journal of Australia 1995; 163:390.

Adverse Drug Reactions Advisory Committee. Talking about fluoxetine. Australian Adverse Drug Reaction Bulletin 1994; 13:14.

Anonymous. Selective serotonin reuptake inhibitors and SIADH. Adverse Drug Reactions Advisory Committee. Medical Journal of Australia 1996; 164:562.

Jackson C Carson W Marowitz J Mintzer J. SIADH associated with fluoxetine and sertraline therapy [letter]. American Journal of Psychiatry 1995; 152:809–810.

Thornton SL Resch DS. SIADH associated with sertraline therapy [letter]. American Journal of Psychiatry 1995; 152:809.

Ball CJ Herzberg JS. Hyponatraemia and selective serotonin reuptake inhibitors. International Journal of Geriatric Psychiatry 1994; 9:819–822.

Blacksten JV Birt JA. Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine. Annals of Pharmacotherapy 1993; 27:723–724.

Burke D Fanker S. Fluoxetine and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Australian and New Zealand Journal of Psychiatry 1996; 30:295–298.

Voegeli J Baumann P. Inappropriate secretion of antidiuretic hormone and SSRIs [letter]. British Journal of Psychiatry 1996; 169:524–525.

Fanker S Burke D. Fluoxetine-induced SIADH: most likely in the elderly? [letter] Australian and New Zealand Journal of Psychiatry 1996; 30:299–301.

Adverse Drug Reactions Advisory Committee (ADRAC). Selective serotonin reuptake inhibitors and SIADH. Medical Journal of Australia 1996; 164:562.

Tierney WM Martin DK Greenlee MC Zerbe RL McDonald CJ. The prognosis of hyponatraemia at hospital admission. Journal of General Internal Medicine 1986; 1:380–385.

Rider JM Mauger TF Jameson JP Notman DD. Water handling in patients receiving haloperidol decanoate. Annals of Pharmacotherapy 1995; 29:663–666.

Wilton NM. The fishing news. Australian and New Zealand Journal of Psychiatry 1996; 30:435–441.

Berk M Terre-Blanche MJ Maude C Lucas MD Mendelsohn M O'Neill-Kerr AJ. Season of birth and schizophrenia: southern hemisphere data. Australian and New Zealand Journal of Psychiatry 1996; 30:220–222.

Hare EH. Season of birth in schizophrenia and neurosis. American Journal of Psychiatry 1975; 132:1168–1171.

Parker G Balza B. Season of birth and schizophrenia—an equatorial study. Acta Psychiatrica Scandinavica 1977; 56:143–146.

McGrath J Welham J Pemberton M. Month of birth, hemisphere of birth and schizophrenia. British Journal of Psychiatry 1995; 167:783–785.

Krupinski J Stoller A King D. Season of birth in schizophrenia: an Australian study. Australian and New Zealand Journal of Psychiatry 1976; 10:311–314.